vs
FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）与Immunovant, Inc.（IMVT）财务数据对比。点击上方公司名可切换其他公司
FLEXIBLE SOLUTIONS INTERNATIONAL INC的季度营收约是Immunovant, Inc.的1.1倍（$9.1M vs $8.4M），FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高（-5.1% vs -899.0%，领先894.0%），Immunovant, Inc.同比增速更快（140.7% vs -0.5%），FLEXIBLE SOLUTIONS INTERNATIONAL INC自由现金流更多（$-4.0M vs $-59.8M）
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
FSI vs IMVT — 直观对比
营收规模更大
FSI
是对方的1.1倍
$8.4M
营收增速更快
IMVT
高出141.3%
-0.5%
净利率更高
FSI
高出894.0%
-899.0%
自由现金流更多
FSI
多$55.8M
$-59.8M
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $8.4M |
| 净利润 | $-460.9K | $-75.3M |
| 毛利率 | 29.4% | — |
| 营业利润率 | 11.6% | -896.2% |
| 净利率 | -5.1% | -899.0% |
| 营收同比 | -0.5% | 140.7% |
| 净利润同比 | -167.8% | -26.7% |
| 每股收益（稀释后） | $-0.03 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSIIMVT
| Q4 25 | $9.1M | — | ||
| Q3 25 | $10.6M | — | ||
| Q2 25 | $11.4M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $9.2M | — | ||
| Q3 24 | $9.3M | — | ||
| Q2 24 | $10.5M | — | ||
| Q1 24 | $9.2M | $8.4M |
净利润FSIIMVT
| Q4 25 | $-460.9K | — | ||
| Q3 25 | $-503.4K | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $-277.7K | — | ||
| Q4 24 | $679.6K | — | ||
| Q3 24 | $611.9K | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $457.2K | $-75.3M |
毛利率FSIIMVT
| Q4 25 | 29.4% | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | 47.4% | — | ||
| Q1 25 | 26.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | 40.9% | — | ||
| Q2 24 | 37.4% | — | ||
| Q1 24 | 30.6% | — |
营业利润率FSIIMVT
| Q4 25 | 11.6% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 29.0% | — | ||
| Q1 25 | -0.9% | — | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 8.3% | -896.2% |
净利率FSIIMVT
| Q4 25 | -5.1% | — | ||
| Q3 25 | -4.8% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 5.0% | -899.0% |
每股收益（稀释后）FSIIMVT
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.04 | — | ||
| Q2 25 | $0.15 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $0.04 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $635.4M |
| 总债务越低越好 | $4.4M | — |
| 股东权益账面价值 | $38.9M | $617.8M |
| 总资产 | $61.8M | $666.4M |
| 负债/权益比越低杠杆越低 | 0.11× | — |
8季度趋势，按日历期对齐
现金及短期投资FSIIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $10.0M | — | ||
| Q1 25 | $11.0M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $13.0M | — | ||
| Q2 24 | $9.2M | — | ||
| Q1 24 | $8.3M | $635.4M |
总债务FSIIMVT
| Q4 25 | $4.4M | — | ||
| Q3 25 | $7.1M | — | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $8.8M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $8.3M | — | ||
| Q1 24 | $8.0M | — |
股东权益FSIIMVT
| Q4 25 | $38.9M | — | ||
| Q3 25 | $39.0M | — | ||
| Q2 25 | $39.4M | — | ||
| Q1 25 | $38.4M | — | ||
| Q4 24 | $38.0M | — | ||
| Q3 24 | $36.9M | — | ||
| Q2 24 | $36.2M | — | ||
| Q1 24 | $36.0M | $617.8M |
总资产FSIIMVT
| Q4 25 | $61.8M | — | ||
| Q3 25 | $58.4M | — | ||
| Q2 25 | $58.2M | — | ||
| Q1 25 | $61.7M | — | ||
| Q4 24 | $60.0M | — | ||
| Q3 24 | $57.8M | — | ||
| Q2 24 | $56.3M | — | ||
| Q1 24 | $57.6M | $666.4M |
负债/权益比FSIIMVT
| Q4 25 | 0.11× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $-59.8M |
| 自由现金流率自由现金流/营收 | -44.3% | -714.4% |
| 资本支出强度资本支出/营收 | 11.7% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-591.7K | $-214.6M |
8季度趋势，按日历期对齐
经营现金流FSIIMVT
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $-544.3K | — | ||
| Q4 24 | $-2.2M | — | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $5.9M | — | ||
| Q1 24 | $-604.8K | $-59.7M |
自由现金流FSIIMVT
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $39.4K | — | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | $-898.4K | — | ||
| Q4 24 | $-4.3M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $4.7M | — | ||
| Q1 24 | $-1.1M | $-59.8M |
自由现金流率FSIIMVT
| Q4 25 | -44.3% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | -12.0% | — | ||
| Q4 24 | -47.0% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 44.9% | — | ||
| Q1 24 | -11.7% | -714.4% |
资本支出强度FSIIMVT
| Q4 25 | 11.7% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 11.3% | — | ||
| Q1 24 | 5.2% | 1.8% |
现金转化率FSIIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.27× | — | ||
| Q3 24 | 4.05× | — | ||
| Q2 24 | 4.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
